Royal Bank Of Canada Boosts Uniphar (LON:UPR) Price Target to GBX 480

Key Points

• Royal Bank of Canada raised the price target for Uniphar (LON:UPR) from GBX 470 to GBX 480, indicating a potential upside of 39.53% from the current stock price.
• The stock currently holds a consensus rating of "Moderate Buy" with an average price target of GBX 427.50, according to MarketBeat data.
• Uniphar's shares opened at GBX 344, showing a market capitalization of approximately £892.93 million and a notable price-to-earnings ratio of 1,404.08.

Uniphar (LON:UPR - Get Free Report) had its target price hoisted by research analysts at Royal Bank Of Canada from GBX 470 to GBX 480 in a research report issued to clients and investors on Tuesday,Digital Look reports. The firm currently has an "outperform" rating on the stock. Royal Bank Of Canada's target price indicates a potential upside of 39.53% from the company's current price.

Other equities research analysts have also recently issued reports about the stock. Shore Capital reissued a "buy" rating on shares of Uniphar in a research note on Thursday, May 29th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a GBX 375 price objective on shares of Uniphar in a research note on Wednesday, July 30th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, Uniphar presently has a consensus rating of "Moderate Buy" and an average price target of GBX 427.50.

Uniphar Stock Down 0.9%

Shares of LON UPR opened at GBX 344 on Tuesday. The stock has a market capitalization of £892.93 million, a price-to-earnings ratio of 1,404.08 and a beta of 0.75. Uniphar has a 52 week low of GBX 163 and a 52 week high of GBX 368. The firm has a 50-day moving average price of GBX 334.18 and a 200 day moving average price of GBX 285.96. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.